Start with human-study records and examine what is actually measured. An empty completed-summary view is a coverage gap, not proof that no human research exists.
Browse the studiesKeep human participants separate from animal models and human-derived cell work.
Look for verified intervention identity, comparator and follow-up.
Do not interpret missing adverse-event reporting as evidence of safety.
Selected from the completed-summary collection, not a systematic review or exhaustive literature search. Human reports appear first; reviews and preclinical work retain their labels.
A retrospective chart review explored reported knee-pain relief after BPC 157, alone or with thymosin-beta-4 (TB4). This was not a randomized treatment comparison.
Follow-up varied, and no specific tools measured function, quality of life, stiffness, or daily activities. Retrospective patient reports cannot establish treatment effectiveness.
This uncontrolled pilot assessed compounded BPC-157 for symptoms of interstitial cystitis after pentosan polysulfate treatment failure.
There was no placebo or comparator group, outcomes were patient-reported, and only 12 women were treated at one private clinic. The design cannot establish causality or uncommon harms.
Researchers used physician-checked automated extraction of US clinical notes from 2020–2026 to describe BPC-157 use and reported outcomes.
Response direction was missing for 65.9%. Co-treatments, reporting biases and imperfect extraction prevent conclusions about effectiveness. Adverse events were probably under-reported.
This preprint analyzed an independent public testing dataset to assess purity, measured peptide abundance, and endotoxin contamination in gray-market research peptides, and compared costs with pharmaceutical alternatives.
The authors caution that consumer-directed third-party testing captures only a small fraction of the safety profile relevant to people injecting these preparations.
Mechanistic research compared tendon explants and cultured tendon fibroblasts with and without BPC 157 to investigate tendon-healing pathways.
No author-stated limitations were available in the abstract. These were tissue and cell experiments, not evidence of improved tendon healing or established safety in people.